Risks of proton pump inhibitors for patients with cirrhosis: The controversy remains.
Gastroenterology and Hepatology Unit, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.|Gastroenterology and Hepatology Unit, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.
Ângelo Zambam
ÂZ
de Mattos
Gastroenterology and Hepatology Unit, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.|Post-Graduation Course of Hepatology, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
Suelen Aparecida da Silva
SADS
Miozzo
Gastroenterology and Hepatology Unit, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.|Post-Graduation Course of Hepatology, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.|Gastroenterology and Hepatology Unit, Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil.
Cristiane Valle
CV
Tovo
Gastroenterology and Hepatology Unit, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.|Post-Graduation Course of Hepatology, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
Angelo Alves
AA
de Mattos
D005355:Fibrosis; D006801:Humans; D008103:Liver Cirrhosis; D054328:Proton Pump Inhibitors; D012306:Risk
D054328:Proton Pump Inhibitors